Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Boston Scientific Corporation; Medtronic; Abbott Vascular; NEPTUNE; SURMODICS
• Grant Support/Research Contract (Institutional) - Bard Medical; Penumbra
• Equity/Stock(s)/Options (Personal) - TRUVIC; INNOVA VASCULAR